capsaicin has been researched along with Diabetic Neuropathies in 93 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (4.30) | 18.7374 |
1990's | 25 (26.88) | 18.2507 |
2000's | 21 (22.58) | 29.6817 |
2010's | 34 (36.56) | 24.3611 |
2020's | 9 (9.68) | 2.80 |
Authors | Studies |
---|---|
Casale, R | 1 |
Leavell, Y; Simpson, DM | 1 |
Alexander, B; Baskaran, P; Bennis, J; Gustafson, N; Louis, S; Mohandass, A; Nemenov, MI; Premkumar, LS; Thyagarajan, B | 1 |
Cirilli, I; Dludla, PV; Hanser, S; Jack, B; Mabhida, SE; Marcheggiani, F; Mazibuko-Mbeje, SE; Nkambule, BB; Ntamo, Y; Nyambuya, TM; Ziqubu, K | 1 |
Al-Shebab, U; Averell, N; Chiplunkar, M; Coombs, K; Goodwin, B; Janora, D; Salerno, R; Sannoh, U; Shah, V | 1 |
Jang, HN; Oh, TJ | 1 |
Egharevba, T; Gritsenko, K; Landrum, O; Marcondes, L | 1 |
Cios, A; Filipek, B; Hubicka, U; Kubacka, M; Kwiecień, A; Marona, H; Pociecha, K; Rapacz, A; Sałat, K; Waszkielewicz, AM; Wyska, E; Żuromska-Witek, B | 1 |
Abrams, RMC; Pedowitz, EJ; Simpson, DM | 1 |
Charokopou, M; Pantiri, K; Stoker, M; Treur, M; van Nooten, F | 1 |
Campanucci, VA; Ianowski, JP; Jagadeeshan, S; Lam, D; Momeni, Z; Theaker, M; Yamamoto, Y | 1 |
Jäger-Becker, D | 1 |
Chomjit, A; Kulkantrakorn, K; Napunnaphat, P; Sithinamsuwan, P; Suwankanoknark, J; Tharavanij, T | 1 |
Chen, X; Duan, Y; Grant, MB; Obukhov, AG; Riley, AM; Welch, MA; White, FA | 1 |
Carroll, D; Gabriel, ZL; Hall, GC; McQuay, HJ; Morant, SV | 1 |
Cole, P; Derry, S; Moore, RA; Sven-Rice, A; Tan, T | 1 |
Besson, M; Sprenger, T; Suter, MR; Taub, E | 1 |
Curry, A | 1 |
Al-Khrasani, M; Fürst, S; Khalefa, BI; Mousa, SA; Schäfer, M; Shakibaei, M; Shaqura, M; Zöllner, C | 1 |
Cui, YY; Li, YQ; Qi, J; Shi, J; Wu, HH; Xu, H | 1 |
Brito, JP; Carranza Leon, BG; Griebeler, ML; Montori, VM; Morey-Vargas, OL; Murad, MH; Phung, OJ; Tsapas, A; Wang, Z | 1 |
Callaghan, BC; Feldman, EL | 1 |
Calabek, B; Callaghan, B; Feldman, EL | 1 |
Bang, S; Berta, T; Ji, RR; Kim, YH; Oh, SB; Wang, F; Xu, ZZ; Zhang, Y | 1 |
Burness, CB; McCormack, PL | 1 |
Charrua, A; Di Marzo, V; Martins, D; Morgado, C; Piscitelli, F; Silva, M; Tavares, I | 1 |
Gibbs, LM; Lindsay, TJ; Snyder, MJ | 1 |
Andries, L; Byttebier, G; Cras, P; De Schepper, S; Meert, T; Nuydens, R; Plaghki, L; Ragé, M; Schrijvers, D; Streffer, J; Timmers, M; Van Acker, N; Vermeirsch, H | 1 |
Jacobs, H; Katz, N; Lambourg, B; Long, SK; Robinson-Papp, J; Schregardus, DS; Simpson, DM; Snijder, RJ; Stoker, M; Van, J | 1 |
Jacobs, H; Katz, N; Long, SK; Ortega, E; Pazdera, L; Perrot, S; Snijder, RJ; Stoker, M; van der Stoep, M; Vinik, AI; Vinik, EJ | 1 |
Cole, P; Derry, S; Moore, RA; Rice, AS; Tan, T | 1 |
Challapalli, SC; Smith, PJ; Zhang, F | 1 |
Derry, S; Lloyd, R; McQuay, HJ; Moore, RA | 1 |
Ziegler, D | 1 |
Kempler, P | 2 |
Keppel Hesselink, JM; Kopsky, DJ | 1 |
Ghazi-Khansari, M; Jaberi, E; Mohammadi-Farani, A; Sahebgharani, M; Sepehrizadeh, Z | 1 |
Lu, B; Murphy, FT; Peppin, JF; Tobias, JK; Vanhove, GF; Webster, LR | 1 |
Brady, KL; Campbell, CM; Campbell, JN; Kelly, M; Kipnes, MS; Petersen, KL; Rowbotham, MC; Schmidt, WK; Stouch, BC | 1 |
Duan, JH; Han, WJ; Hu, SJ; Luo, C; Miao, B; Sun, W; Wang, WT; Wang, XC; Ye, X | 1 |
Furukawa, Y; Jinno, H; Ohkawara, S; Tanaka-Kagawa, T | 1 |
Cunha, JM; Jesus, CH; Neufeld, M; Schreiber, AK | 1 |
Kulkantrakorn, K; Lorsuwansiri, C; Meesawatsom, P | 1 |
Belan, PV; Borisyuk, AL; Duzhyy, DE; Khomula, EV; Viatchenko-Karpinski, VY; Voitenko, NV | 1 |
Kimura, M; Suzuki, K | 1 |
Ahmad, M; Goucke, CR | 1 |
Coppini, DV; Potter, J; Spruce, MC | 1 |
Bakoshi, S; Inoue, M; Rashid, MH; Ueda, H | 1 |
Llewelyn, JG | 1 |
Vinik, AI | 1 |
Collins, L; Fotinos, C; Newton, WP | 1 |
Bergren, DR; Rendell, MS | 1 |
Chong, MS; Hester, J | 1 |
Bromberg, MB; Herrmann, DN | 1 |
Darzins, PJ; Khalil, Z; Ogrin, R | 1 |
Robinson-Papp, J; Simpson, DM | 1 |
Banovcin, P; Cervenkova, V; Ciljakova, M; Durdik, P; Hanacek, J; Varechova, S | 1 |
Boult, L; Brown, B; Guay, D; Marciniak, BH; Peterson, B | 1 |
Kerstein, MD; Polsky, S | 1 |
Sokołowski, P | 1 |
Watson, CP | 1 |
Dorfmüller, P; Hohenleutner, U; Korting, HC; Landthaler, M; Stolz, W; Wlotzke, U | 1 |
Li Wan Po, A; Zhang, WY | 1 |
Ho, LT; Zochodne, DW | 1 |
Crain, GM; Gelber, DA; Jung, S; Markwell, SJ; Pfeifer, MA; Ross, DR; Schrage, JP; Schumer, MP | 1 |
Bryson, HM; Rains, C | 1 |
Inoue, K; Kunimoto, M; Masaki, T; Ogata, K; Takao, F | 1 |
Gilhar, A; Markovits, E | 1 |
Handevidt, F | 1 |
Jensen, PG; Larson, JR | 1 |
Beyer, J; Engelbach, M; Forst, T; Goitom, K; Kunt, T; Löbig, M; Pfützner, A; Pohlmann, T; Schulz, G | 1 |
Cameron, NE; Cotter, MA; Ellington, HC; Ross, RA | 1 |
Ollat, H | 1 |
Boulton, AJ; Veves, A | 1 |
Brooks, PJ; Francisco, GE | 1 |
Aronin, N; Chad, DA; Dyess, E; Lundstrom, R; McKeon, P; Molitch, M; Ross, D; Schipper, HM; Stall, G; Tarsy, D | 1 |
Badger, GB; Fries, TJ; Lewis, GA; Tandan, R | 1 |
Badger, GB; Fries, TJ; Krusinski, PB; Lewis, GA; Tandan, R | 1 |
Brenton, W; Carr, RW; Delaney, CA; Kiln, JC; Pano, I; Rabavilas, A; Roberts, RG; Westerman, RA | 1 |
Basha, KM; Whitehouse, FW | 1 |
Lipton, MN; Scheffler, NM; Sheitel, PL | 1 |
Abraham, RR; Levy, DM; Tomlinson, DR | 1 |
Cotton, P | 1 |
Aronin, N; Clements, RS; Leeman, SE | 1 |
Ross, DR; Varipapa, RJ | 1 |
Ohnishi, A | 1 |
Chun, AL; Gerald, MC; Kudlacz, EM; Skau, KA; Wallace, LJ | 1 |
37 review(s) available for capsaicin and Diabetic Neuropathies
Article | Year |
---|---|
Capsaicin 179-mg cutaneous patch in the treatment of post-surgical neuropathic pain: a scoping review of current evidence and place in therapy.
Topics: Adult; Capsaicin; Diabetic Neuropathies; Humans; Neuralgia; Neuralgia, Postherpetic; Pain, Postoperative; Transdermal Patch | 2021 |
The role of the capsaicin 8% patch in the treatment of painful diabetic peripheral neuropathy.
Topics: Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Neuralgia; Pain Management | 2022 |
Capsaicin, its clinical significance in patients with painful diabetic neuropathy.
Topics: Administration, Topical; Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Pain; Quality of Life | 2022 |
Topical capsaicin for the management of painful diabetic neuropathy: a narrative systematic review.
Topics: Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Neuralgia | 2023 |
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy.
Topics: Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Duloxetine Hydrochloride; Humans; Neuralgia; Quality of Life; United States | 2023 |
Painful diabetic peripheral neuropathy of the feet: integrating prescription-strength capsaicin into office procedures.
Topics: Administration, Cutaneous; Administration, Topical; Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Pain | 2023 |
A critical review of the capsaicin 8% patch for the treatment of neuropathic pain associated with diabetic peripheral neuropathy of the feet in adults.
Topics: Adult; Capsaicin; Diabetes Mellitus; Diabetic Neuropathies; Humans; Neuralgia; Pain Management; Quality of Life | 2021 |
Capsaicin 8% Patch Versus Oral Neuropathic Pain Medications for the Treatment of Painful Diabetic Peripheral Neuropathy: A Systematic Literature Review and Network Meta-analysis.
Topics: Administration, Oral; Analgesics; Capsaicin; Diabetic Neuropathies; Humans; Neuralgia; Transdermal Patch | 2017 |
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Ointments; Pain, Postoperative; Randomized Controlled Trials as Topic | 2013 |
[New concepts in the pathophysiology, diagnosis and treatment of neuropathic pain].
Topics: Analgesics; Capsaicin; Clonidine; Diabetic Neuropathies; Headache; Humans; Neuralgia; Pain Measurement; Sensory System Agents; Treatment Outcome | 2013 |
Pharmacologic interventions for painful diabetic neuropathy: An umbrella systematic review and comparative effectiveness network meta-analysis.
Topics: Analgesics, Opioid; Anticonvulsants; Antidepressive Agents, Tricyclic; Bias; Capsaicin; Diabetic Neuropathies; Humans; Pain; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2014 |
Therapy for diabetic neuropathy: an overview.
Topics: Analgesics, Opioid; Animals; Capsaicin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Neuralgia | 2014 |
Capsaicin 8 % Patch: A Review in Peripheral Neuropathic Pain.
Topics: Capsaicin; Diabetic Neuropathies; Humans; Neuralgia, Postherpetic; Pain Management; Peripheral Nervous System Diseases; Pregabalin; Sensory System Agents; Transdermal Patch | 2016 |
Treating Painful Diabetic Peripheral Neuropathy: An Update.
Topics: Administration, Topical; Amines; Amitriptyline; Analgesics; Analgesics, Opioid; Anesthetics, Local; Capsaicin; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Isosorbide Dinitrate; Lidocaine; Phenols; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sensory System Agents; Serotonin and Noradrenaline Reuptake Inhibitors; Tapentadol; Tramadol; Transcutaneous Electric Nerve Stimulation; Vasodilator Agents; Venlafaxine Hydrochloride | 2016 |
What role for capsaicin in diabetic peripheral neuropathy?
Topics: Administration, Cutaneous; Capsaicin; Diabetic Neuropathies; Disease Management; Humans; Neuralgia | 2016 |
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Pain; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Numbers Needed To Treat; Ointments; Pain, Postoperative; Randomized Controlled Trials as Topic | 2017 |
Topical capsaicin for chronic neuropathic pain in adults.
Topics: Administration, Topical; Adult; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; HIV Infections; Humans; Neuralgia; Neuralgia, Postherpetic; Ointments; Pain, Postoperative | 2009 |
Painful diabetic neuropathy: advantage of novel drugs over old drugs?
Topics: Amitriptyline; Analgesics; Antioxidants; Antipruritics; Capsaicin; Chronic Disease; Diabetic Neuropathies; Humans; Hypoglycemic Agents; Insulin; Pain; Selective Serotonin Reuptake Inhibitors; Thioctic Acid | 2009 |
[Sensory disorder and clinical care in painful diabetic neuropathy].
Topics: Antidepressive Agents; Capsaicin; Carbamazepine; Chronic Disease; Clonidine; Diabetic Neuropathies; Humans; Insulin; Nerve Fibers; Sensation Disorders | 2002 |
Management strategies for the treatment of neuropathic pain in the elderly.
Topics: Aged; Analgesics, Opioid; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Capsaicin; Cognitive Behavioral Therapy; Diabetic Neuropathies; Herpes Simplex; Humans; Lidocaine; Nerve Block; Nervous System Diseases; Neuralgia; Pain; Pain Management; Physical Therapy Modalities; Stroke; Tramadol | 2002 |
The pathogenesis and management of painful diabetic neuropathy: a review.
Topics: Anti-Arrhythmia Agents; Anticonvulsants; Antidepressive Agents; Blood Glucose; Capsaicin; Diabetic Foot; Diabetic Neuropathies; Humans; N-Methylaspartate; Pain; Selective Serotonin Reuptake Inhibitors; Transcutaneous Electric Nerve Stimulation | 2003 |
Management of neuropathy and foot problems in diabetic patients.
Topics: Amputation, Surgical; Capsaicin; Diabetic Foot; Diabetic Neuropathies; Diagnosis, Differential; Humans; Hyperglycemia; Nerve Compression Syndromes; Risk Assessment; Risk Factors | 2003 |
Clinical inquiries. What is the best treatment for diabetic neuropathy?
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Diabetic Neuropathies; Evidence-Based Medicine; Humans | 2004 |
[Treatment of neuropathies].
Topics: Adjuvants, Immunologic; Capsaicin; Diabetic Neuropathies; Diagnosis, Differential; Humans; Liver Diseases; Peripheral Nervous System Diseases; Randomized Controlled Trials as Topic; Thiamine; Treatment Outcome | 2004 |
Diabetic painful neuropathy: current and future treatment options.
Topics: Analgesics, Opioid; Anticonvulsants; Capsaicin; Controlled Clinical Trials as Topic; Diabetes Mellitus; Diabetic Neuropathies; Humans; Hypoglycemic Agents; Pain; Pain Management; Selective Serotonin Reuptake Inhibitors | 2007 |
Safety profile of treatment in diabetic peripheral neuropathic pain.
Topics: Administration, Topical; Analgesics; Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Capsaicin; Cyclohexanols; Diabetic Neuropathies; Duloxetine Hydrochloride; gamma-Aminobutyric Acid; Humans; Pain; Pregabalin; Thiophenes; Venlafaxine Hydrochloride | 2007 |
[Capsaicin in pain therapy].
Topics: Arthralgia; Capsaicin; Cluster Headache; Diabetic Neuropathies; Herpes Zoster; Humans; Neuralgia; Trigeminal Neuralgia | 1994 |
Topical capsaicin as an adjuvant analgesic.
Topics: Administration, Topical; Analgesics; Animals; Arthritis; Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Humans; Mastectomy; Neuralgia; Pain, Postoperative | 1994 |
[The interdisciplinary aspects of notalgia paraesthetica].
Topics: Aged; Back Pain; Biopsy; Capsaicin; Chronic Disease; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Diagnosis, Differential; Humans; Male; Multiple Endocrine Neoplasia Type 2a; Paresthesia; Pigmentation Disorders; Pruritus; Skin | 1994 |
The effectiveness of topically applied capsaicin. A meta-analysis.
Topics: Administration, Topical; Capsaicin; Diabetic Neuropathies; Humans; Osteoarthritis; Pain; Psoriasis | 1994 |
Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Herpes Zoster; Humans; Middle Aged; Neuralgia; Osteoarthritis | 1995 |
Capsaicin--an effective topical treatment in pain.
Topics: Administration, Cutaneous; Analgesics; Capsaicin; Chronic Disease; Diabetic Neuropathies; Herpes Simplex; Humans; Neuralgia; Pain; Rheumatic Diseases | 1997 |
Peripheral neuropathy in persons with diabetes.
Topics: Analgesics; Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Diabetic Foot; Diabetic Neuropathies; Diagnosis, Differential; Humans; Hypoglycemia; Nursing Care; Pain; Physical Examination; Quality of Life | 2001 |
Management of painful diabetic neuropathy.
Topics: Aged; Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Diabetic Neuropathies; Humans; Pain Management | 2001 |
[Pharmacological treatment of neuropathic pain].
Topics: Anesthetics, Local; Anticonvulsants; Antidepressive Agents; Baclofen; Capsaicin; Chronic Disease; Diabetic Neuropathies; Humans; Narcotics; Neuralgia; Pain; Peripheral Nervous System Diseases | 1992 |
Drug therapy of diabetic neuropathy.
Topics: Aldehyde Reductase; Anti-Arrhythmia Agents; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Capsaicin; Diabetic Neuropathies; Humans; Psychotropic Drugs | 1992 |
[The spinal primary sensory neuron].
Topics: Adult; Aged; Animals; Capsaicin; Diabetic Neuropathies; Dysautonomia, Familial; Fabry Disease; Ganglia, Spinal; Humans; Male; Mercury Poisoning; Neoplasms; Nervous System Diseases; Neurons, Afferent; Rats; Rats, Inbred Strains; Sensation; Spinal Cord | 1988 |
17 trial(s) available for capsaicin and Diabetic Neuropathies
Article | Year |
---|---|
[In process].
Topics: Administration, Cutaneous; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Humans; Neuralgia; Peripheral Nervous System Diseases | 2016 |
0.075% capsaicin lotion for the treatment of painful diabetic neuropathy: A randomized, double-blind, crossover, placebo-controlled trial.
Topics: Adult; Capsaicin; Cross-Over Studies; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuralgia; Pain Management; Sensory System Agents; Skin Cream | 2019 |
Capsaicin 8% Patch in Painful Diabetic Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Study.
Topics: Blood Glucose; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Pain Measurement; Sensory System Agents; Sleep Wake Disorders; Statistics, Nonparametric; Time Factors; Transdermal Patch | 2017 |
Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
Topics: Administration, Cutaneous; Adult; Aged; Capsaicin; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Neuralgia; Outcome Assessment, Health Care; Sensory System Agents; Standard of Care | 2016 |
Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain.
Topics: Aged; Anesthetics, Local; Capsaicin; Diabetic Neuropathies; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Pain; Peripheral Nervous System Diseases; Polyneuropathies; Sensory System Agents; Transdermal Patch; Treatment Outcome | 2011 |
Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy.
Topics: Administration, Cutaneous; Aged; Analgesics; Capsaicin; Clonidine; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Nociceptive Pain; Nociceptors; Pain Measurement; Sensory System Agents; Treatment Outcome | 2012 |
0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial.
Topics: Administration, Topical; Adult; Aged; Capsaicin; Cross-Over Studies; Diabetic Neuropathies; Double-Blind Method; Exanthema; Female; Follow-Up Studies; Gels; Humans; Male; Middle Aged; Treatment Outcome | 2013 |
The effect of sensory nerve stimulation on sensory nerve function in people with peripheral neuropathy associated with diabetes.
Topics: Aged; Capillaries; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Electric Stimulation Therapy; Female; Humans; Male; Microcirculation; Middle Aged; Neurogenic Inflammation; Neurons, Afferent; Oxygen Consumption; Pain Measurement; Pain Threshold; Peripheral Nerves; Placebos; Sensation Disorders; Sensory Thresholds; Skin; Treatment Outcome | 2007 |
A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.
Topics: Analgesics; Capsaicin; Diabetic Neuropathies; Exercise Therapy; Female; Glycated Hemoglobin; Humans; Imipramine; Male; Mexiletine; Middle Aged; Models, Neurological; Muscles; Oxazoles; Oxazolidinones; Pain; Pain Management; Pain Measurement; Piroxicam | 1993 |
The influence of local capsaicin treatment on small nerve fibre function and neurovascular control in symptomatic diabetic neuropathy.
Topics: Administration, Topical; Capsaicin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Humans; Male; Middle Aged; Nerve Fibers; Phytotherapy; Pilot Projects; Sensory Thresholds | 2002 |
Effect of treatment with capsaicin on daily activities of patients with painful diabetic neuropathy. Capsaicin Study Group.
Topics: Activities of Daily Living; Administration, Topical; Capsaicin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Leisure Activities; Locomotion; Male; Middle Aged; Pain; Sleep; Work | 1992 |
Topical capsaicin in painful diabetic neuropathy. Effect on sensory function.
Topics: Administration, Topical; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neurologic Examination; Neurons, Afferent; Pain, Intractable | 1992 |
Topical capsaicin in painful diabetic neuropathy. Controlled study with long-term follow-up.
Topics: Administration, Topical; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Humans; Male; Middle Aged; Pain, Intractable | 1992 |
Capsaicin: a therapeutic option for painful diabetic neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Patient Education as Topic | 1991 |
Treatment of painful diabetic neuropathy with capsaicin 0.075%.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Pain Measurement | 1991 |
Treatment of painful diabetic neuropathy with topical capsaicin. A multicenter, double-blind, vehicle-controlled study. The Capsaicin Study Group.
Topics: Administration, Topical; Capsaicin; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Pain Measurement; Pharmaceutical Vehicles | 1991 |
Compliance problems, placebo effect cloud trials of topical analgesic.
Topics: Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Double-Blind Method; HIV Infections; Humans; Ointments; Patient Compliance; Peripheral Nervous System Diseases; Placebo Effect | 1990 |
39 other study(ies) available for capsaicin and Diabetic Neuropathies
Article | Year |
---|---|
Evaluation of a polymer-coated nanoparticle cream formulation of resiniferatoxin for the treatment of painful diabetic peripheral neuropathy.
Topics: Analgesics; Animals; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diterpenes; Pain; Rats; Swine; Swine, Miniature; TRPV Cation Channels | 2023 |
KM-416, a novel phenoxyalkylaminoalkanol derivative with anticonvulsant properties exerts analgesic, local anesthetic, and antidepressant-like activities. Pharmacodynamic, pharmacokinetic, and forced degradation studies.
Topics: Analgesics; Anesthetics, Local; Animals; Anticonvulsants; Antidepressive Agents; Area Under Curve; Brain; Capsaicin; Diabetic Neuropathies; Drug Stability; Epilepsy; Guinea Pigs; Hemodynamics; Male; Mice; Neuralgia; Pain Measurement; Patch-Clamp Techniques; Rats; Rats, Wistar; Sodium Channel Blockers | 2020 |
RAGE-dependent potentiation of TRPV1 currents in sensory neurons exposed to high glucose.
Topics: Animals; Calcium Signaling; Capsaicin; Diabetic Neuropathies; Evoked Potentials; Ganglia, Spinal; Glucose; Humans; Long-Term Potentiation; Mice; Mice, Knockout; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Sensory Receptor Cells; TRPV Cation Channels | 2018 |
Capsaicin (QUTENZA*) and diabetic neuropathic pain Harmful, and no tangible efficacy.
Topics: Capsaicin; Diabetic Neuropathies; Humans; Sensory System Agents; Transdermal Patch | 2017 |
Long-Term Diabetic Microenvironment Augments the Decay Rate of Capsaicin-Induced Currents in Mouse Dorsal Root Ganglion Neurons.
Topics: Animals; Calcium; Capsaicin; Diabetic Neuropathies; Disease Models, Animal; Fluoresceins; Fluorescent Dyes; Ganglia, Spinal; Gene Expression Regulation; Glucose; Ion Transport; Male; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Optical Imaging; Pain; Patch-Clamp Techniques; Primary Cell Culture; Reactive Oxygen Species; Single-Cell Analysis; TRPV Cation Channels | 2019 |
An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population.
Topics: Acetaminophen; Adolescent; Adult; Aged; Amines; Amitriptyline; Analgesics, Non-Narcotic; Analgesics, Opioid; Anticonvulsants; Capsaicin; Child; Child, Preschool; Codeine; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Drug Combinations; Drug Prescriptions; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydrocodone; Incidence; Infant; Male; Middle Aged; Neuralgia, Postherpetic; Phantom Limb; Practice Patterns, Physicians'; Primary Health Care; Sensory System Agents; United Kingdom; Young Adult | 2013 |
Regaining nerve.
Topics: Bariatric Surgery; Capsaicin; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Weight Loss | 2014 |
New insights into mechanisms of opioid inhibitory effects on capsaicin-induced TRPV1 activity during painful diabetic neuropathy.
Topics: Animals; Blood Glucose; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Ganglia, Spinal; Male; Membrane Potentials; Nerve Growth Factor; Neuralgia; Rats, Wistar; Receptors, Opioid, mu; Sensory Receptor Cells; Spinal Cord; TRPV Cation Channels | 2014 |
Spatio-temporal expression and functional involvement of transient receptor potential vanilloid 1 in diabetic mechanical allodynia in rats.
Topics: Analysis of Variance; Animals; Blotting, Western; Capsaicin; Diabetic Neuropathies; Fluorescent Antibody Technique; Ganglia, Spinal; Gene Expression Profiling; Gene Expression Regulation; Hyperalgesia; Image Processing, Computer-Assisted; Immunohistochemistry; Rats; Real-Time Polymerase Chain Reaction; Ruthenium Red; Spinal Cord; Streptozocin; Time Factors; TRPV Cation Channels | 2014 |
Painful diabetic neuropathy: many similarly effective therapies with widely dissimilar costs.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Capsaicin; Diabetic Neuropathies; Humans; Pain; Selective Serotonin Reuptake Inhibitors | 2014 |
Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade.
Topics: Adult; Aged; Anesthetics, Local; Animals; Antineoplastic Agents; Capsaicin; Diabetic Neuropathies; Female; Flagellin; Ganglia, Spinal; Humans; Hyperalgesia; Lidocaine; Male; Mice; Mice, Knockout; Middle Aged; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neuralgia; Neurofilament Proteins; Neurons; Paclitaxel; Peripheral Nerve Injuries; Sensory System Agents; Toll-Like Receptor 5 | 2015 |
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy.
Topics: Amides; Amidohydrolases; Analgesics, Non-Narcotic; Animals; Arachidonic Acids; Capsaicin; Chronic Pain; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Endocannabinoids; Ethanolamines; Formaldehyde; Male; Medulla Oblongata; Nociceptive Pain; Oleic Acids; Palmitic Acids; Polyunsaturated Alkamides; Rats, Wistar; RNA, Messenger; TRPV Cation Channels | 2016 |
NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy.
Topics: Adult; Aged; Biopsy; Capsaicin; Diabetes Complications; Diabetic Neuropathies; Epidermis; Gene Expression Regulation; Humans; Middle Aged; Nerve Fibers; Nerve Regeneration; Neuropilin-1; Platelet Endothelial Cell Adhesion Molecule-1; Skin; Small Fiber Neuropathy | 2016 |
Cannabinoid CB(1) receptor activation stimulates neurite outgrowth and inhibits capsaicin-induced Ca(2+) influx in an in vitro model of diabetic neuropathy.
Topics: Animals; Calcium; Capsaicin; Diabetic Neuropathies; Dose-Response Relationship, Drug; Dronabinol; Glucose; Hyperglycemia; Indoles; Nerve Growth Factor; Neurites; Neurogenesis; Neurons; Neuroprotective Agents; PC12 Cells; Piperidines; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; RNA, Messenger; Sensory System Agents | 2009 |
[Treatment of neuropathies].
Topics: Adjuvants, Immunologic; Adrenergic Uptake Inhibitors; Amines; Analgesics; Antioxidants; Capsaicin; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Duloxetine Hydrochloride; Gabapentin; gamma-Aminobutyric Acid; Humans; Polyneuropathies; Pregabalin; Sensory System Agents; Thiamine; Thioctic Acid; Thiophenes | 2010 |
A new combination cream for the treatment of severe neuropathic pain.
Topics: Administration, Topical; Analgesics; Capsaicin; Diabetic Neuropathies; Drug Combinations; gamma-Aminobutyric Acid; Humans; Male; Middle Aged; Ointments; Pain; Pain Measurement; Peripheral Nervous System Diseases; Pregabalin | 2010 |
Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray.
Topics: Analgesia; Analgesics; Animals; Benzoxazines; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Down-Regulation; gamma-Aminobutyric Acid; Glutamic Acid; Hyperalgesia; Male; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Nociceptors; Periaqueductal Gray; Rats; Receptor, Cannabinoid, CB1; RNA, Messenger; TRPV Cation Channels; Up-Regulation | 2010 |
Gastrodin inhibits allodynia and hyperalgesia in painful diabetic neuropathy rats by decreasing excitability of nociceptive primary sensory neurons.
Topics: Animals; Benzyl Alcohols; Capsaicin; Diabetic Neuropathies; Glucosides; Hyperalgesia; Rats; Sensory Receptor Cells; Streptozocin | 2012 |
Methylglyoxal activates the human transient receptor potential ankyrin 1 channel.
Topics: Acrolein; Calcium; Calcium Channels; Capsaicin; Cloning, Molecular; Diabetic Neuropathies; HEK293 Cells; Humans; Nerve Tissue Proteins; Pyruvaldehyde; Transient Receptor Potential Channels; TRPA1 Cation Channel; TRPV Cation Channels | 2012 |
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
Topics: Analgesics; Animals; Arachidonic Acids; Behavior, Animal; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Endocannabinoids; Formaldehyde; Hyperalgesia; Indoles; Male; Pain Measurement; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptors, Cannabinoid | 2012 |
Specific functioning of Cav3.2 T-type calcium and TRPV1 channels under different types of STZ-diabetic neuropathy.
Topics: Animals; Calcium; Calcium Channels, T-Type; Capsaicin; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Ganglia, Spinal; Hyperalgesia; Male; Membrane Potentials; Neurons; Patch-Clamp Techniques; Rats; Rats, Wistar; Sensory System Agents; TRPV Cation Channels | 2013 |
Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice.
Topics: Afferent Pathways; Animals; Capsaicin; Diabetic Neuropathies; Disease Models, Animal; Hot Temperature; Hyperalgesia; Injections, Intravenous; Mice; Nerve Fibers, Myelinated; Neurons, Afferent; Pain; Phenotype; Receptors, Drug; Streptozocin | 2003 |
The diabetic neuropathies: types, diagnosis and management.
Topics: Acupuncture Therapy; Administration, Topical; Biopsy; Blood Glucose; Capsaicin; Cerebrospinal Fluid Proteins; Diabetic Neuropathies; Electromyography; Humans; Ointments; Peripheral Nerves; Psychotropic Drugs; Weight Loss | 2003 |
Depressed ventilatory reflexes after capsaicin challenge in streptozotocin-treated rats.
Topics: Analysis of Variance; Animals; Blood Glucose; Body Weight; Capsaicin; Cough; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Glycated Hemoglobin; Male; Nerve Fibers, Unmyelinated; Plethysmography, Whole Body; Pulmonary Ventilation; Rats; Rats, Sprague-Dawley; Streptozocin; Tidal Volume; Time Factors | 2004 |
Chili peppers, nerve regeneration, and clinical trial design.
Topics: Biomarkers; Biopsy; Capsaicin; Capsicum; Clinical Trials as Topic; Diabetic Neuropathies; HIV Infections; Humans; Nerve Fibers, Unmyelinated; Nerve Regeneration; Peripheral Nervous System Diseases; Sensory Receptor Cells; Treatment Outcome | 2007 |
The influence of autonomic neuropathy on cough reflex sensitivity in children with diabetes mellitus type 1.
Topics: Adolescent; Autonomic Nervous System Diseases; Blood Pressure; Capsaicin; Cough; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Heart Rate; Humans; Male; Reflex | 2007 |
Adverse consequences of capsaicin exposure in health care workers.
Topics: Administration, Cutaneous; Capsaicin; Cough; Diabetic Neuropathies; Dyspnea; Humans; Male; Middle Aged; Nursing Staff; Occupational Diseases | 1995 |
Treating wounds associated with decreased sensibility.
Topics: Amitriptyline; Capsaicin; Diabetic Foot; Diabetic Neuropathies; Humans; Shoes; Skin Care | 1995 |
Diabetes mellitus prevents capsaicin from inducing hyperaemia in the rat sciatic nerve.
Topics: Animals; Blood Glucose; Body Weight; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperemia; Male; Myelin Sheath; Neural Conduction; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Sciatic Nerve; Vascular Resistance | 1993 |
[Therapeutic trials with topical capsaicin cream and iontophoretically applied lidocaine for diabetic painful truncal neuropathy].
Topics: Capsaicin; Diabetic Neuropathies; Humans; Hyperesthesia; Iontophoresis; Lidocaine; Male; Middle Aged; Ointments; Pain | 1996 |
The effect of cannabinoids on capsaicin-evoked calcitonin gene-related peptide (CGRP) release from the isolated paw skin of diabetic and non-diabetic rats.
Topics: Animals; Calcitonin Gene-Related Peptide; Cannabinoids; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hindlimb; In Vitro Techniques; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; Receptors, Drug; Reference Values; Rimonabant; Skin | 2002 |
Measuring subjective symptoms.
Topics: Capsaicin; Diabetic Neuropathies; Humans; Pain; Pain Measurement | 1992 |
Capsaicin--a topical analgesic.
Topics: Administration, Cutaneous; Analgesics; Arthritis; Capsaicin; Clinical Trials as Topic; Diabetic Neuropathies; Herpes Zoster; Humans; Pain | 1992 |
Does capsaicin relieve the pain of diabetic neuropathy?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capsaicin; Diabetic Neuropathies; Humans; Middle Aged; Palliative Care | 1990 |
Noxious heat hyperalgesia test instrument.
Topics: Capsaicin; Diabetic Neuropathies; Hot Temperature; Humans; Hyperalgesia; Least-Squares Analysis; Sensory Thresholds; Skin | 1991 |
Topical capsaicin in the treatment of painful diabetic neuropathy.
Topics: Administration, Topical; Capsaicin; Chronic Disease; Diabetic Neuropathies; Humans; Pain | 1991 |
Diminished flare response in neuropathic diabetic patients. Comparison of effects of substance P, histamine, and capsaicin.
Topics: Capsaicin; Diabetic Neuropathies; Female; Histamine; Humans; Male; Middle Aged; Nerve Fibers; Peripheral Nerves; Skin Tests; Substance P | 1987 |
Treatment of painful diabetic neuropathy with topical capsaicin.
Topics: Aged; Capsaicin; Diabetic Neuropathies; Humans; Male; Middle Aged; Neuralgia; Ointments | 1989 |
Diabetes and diuretic-induced alterations in function of rat urinary bladder.
Topics: Animals; Blood Glucose; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Diuresis; DNA; Galactose; Lactose; Male; Muscle Contraction; Organ Size; Pressure; Rats; Rats, Inbred Strains; Sucrose; Urinary Bladder | 1988 |